Expense Reimbursement

How It Works

IRM provides legal and transparent Expense Reimbursement options in the form vouchers, certificates or other services.

Expense Reimbursement Services are designed to meet legislation of Ukraine and EU Clinical Trial Directive (2001/20/EC) and Regulation (536/2014) that states: no incentives or financial inducements are given to incapacitated participants or minors (or either of their legally designated representatives), or to pregnant women, except for compensation for expenses and loss of earnings directly related to participation in the clinical trial.

We also request that any compensation is reviewed and approved by the respective Ethics Committee.

Reimbursement may cover:

2021 Improvements

While the number of clinical trials in Ukraine increasing and their efficiency and quality as well, patient recruitment and retention becomes more crucial.

The success of the trial depends on identifying the right patients for the study and their further engagement to invest their time and effort into drug development. Patient recruitment is considered to be one of the most difficult challenges and it is estimated that 80% of clinical trials do not meet their patient enrolment deadlines.

The above-mentioned challenges have led key players in the pharmaceutical industry to seek external support of specialized companies to expedite the patient recruitment and optimize patient retention processes.